OGN IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action – OGN

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Organon & Co. securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from November 3, 2022, to April 30, 2025, and the lead plaintiff deadline is July 22, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [2][5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]. Group 3: Allegations Against Organon - The lawsuit alleges that Organon made false or misleading statements regarding its product Nexplanon, including an overstated sales growth projection [4]. - It is claimed that Organon would not achieve the projected $1 billion in sales by the end of fiscal year 2025, nor the subsequent $1.5 billion [4]. - The lawsuit also suggests that Organon may not maintain the required $1 billion in free cash flow to sustain its dividend, nor its corporate debt ratings [4].